NAOS YARON (Sr. VP, Operations) received a stock award from PROTALIX BIOTHERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/4/2025ACC: 0001415889-25-023701
Officer· Sr. VP, Operations
Since Sep 2018
+75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
75K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+25K
Price / share
—
Trade value
—
% of position
12.4%
9/3/2025
200.82K→225.82K
Total
Net shares
+25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/3/2025 | A · Award | +25K | — | — | 12.4% | 200.82K | 225.82K |
| Total | +25K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
50K shares
Shares
+50K
Strike price
1.64
Held after
50K
Exercisable
—
9/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock50K shares | 9/3/2025 | A · Award | +50K | 1.64 | — | 50K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned7.11K
Total
7.11K direct7.11K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 7.11K | Direct |
| Total | 7.11K | 7.11K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported